The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 13,500 shares, a decline of 67.1% from the November 15th total of 41,000 shares. Based on an average daily volume of 25,800 shares, the short-interest ratio is presently 0.5 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of NASDAQ CGABL remained flat at $18.92 during mid-day trading on Wednesday. The company had a trading volume of 18,446 shares, compared to its average volume of 22,062. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52 week low of $17.49 and a 52 week high of $20.85. The company has a 50 day moving average price of $19.67 and a 200-day moving average price of $19.12.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Saturday, November 15th. Stockholders of record on Saturday, November 1st will be given a $0.2891 dividend. This represents a $1.16 annualized dividend and a dividend yield of 6.11%. The ex-dividend date is Friday, October 31st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.